2016 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
December 29, 2016
Aptose Biosciences Provides Update on APTO-253 Development
November 14, 2016
Aptose Biosciences Reports Financial Results for the Third Quarter Ended September 30, 2016
November 10, 2016
Aptose To Release Third Quarter Ended September 30, 2016 Financial Results and Hold Conference Call on November 15, 2016
November 3, 2016
Aptose to Present New APTO-253 Data at the 2016 ASH Annual Meeting
October 13, 2016
Aptose Provides Update on FDA Clinical Hold of APTO-253
September 12, 2016
Aptose Submits Formal Response to Clinical Hold for APTO-253
August 9, 2016
Aptose Biosciences Reports Financial Results for the Second Quarter Ended June 30, 2016
August 9, 2016
Aptose Biosciences to Present at Canaccord Genuity 36th Annual Growth Conference
August 4, 2016
Aptose To Release Second Quarter Ended June 30, 2016 Financial Results and Hold Conference Call on August 9, 2016
June 21, 2016
Aptose Biosciences Announces Results of Annual Meeting of Shareholders
June 21, 2016
Aptose Biosciences Provides Corporate Update in Advance of Annual Meeting of Shareholders
June 8, 2016
Aptose Biosciences and CrystalGenomics Announce Exclusive Agreement for Non-Covalent BTK / FLT3 / AURK Inhibitor
May 10, 2016
Aptose Bioscience Reports Results for the First Quarter Ended March 31, 2016
May 2, 2016
Aptose To Release First Quarter Ended March 31, 2016 Financial Results and Hold Conference Call on May 10, 2016
March 29, 2016
Aptose Reports Fourth Quarter and Year End 2015 Results
March 14, 2016
Aptose To Release Fourth Quarter and Year End December 31, 2015 Financial Results and Hold Conference Call on March 29, 2016
March 3, 2016
Aptose to Participate in Upcoming Investor Conferences
February 18, 2016
Aptose to Present at the 2016 RBC Capital Markets Global Healthcare Conference